{"id":344585,"date":"2026-11-12T10:42:29","date_gmt":"2026-11-12T05:12:29","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=344585"},"modified":"2026-11-12T10:42:29","modified_gmt":"2026-11-12T05:12:29","slug":"solar-modules-maker-specialty-medicines-company-and-it-engineering-services-company-stocks-roadmap-highland-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/solar-modules-maker-specialty-medicines-company-and-it-engineering-services-company-stocks-roadmap-highland-list\/","title":{"rendered":"3 Solar Modules Maker, Specialty Medicines Company and IT Engineering Services Company Stocks With a Strong Future Roadmap: Emmvee Photovoltaic Power, Ajanta Pharma and Mindteck (India)"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Emmvee Photovoltaic Power, Ajanta Pharma and Mindteck (India): ROE of 10.4% to 32.3% and FY22 to FY26 revenue CAGR of 8.3% to 73.2%. Prices as of 11 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three solar panel, branded pharma and IT stocks to watch are Emmvee Photovoltaic Power, Ajanta Pharma and Mindteck (India). Their return on equity ranges from 10.4% to 32.3%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.3% to 73.2%. Emmvee Photovoltaic Power leads on both return on equity at 32.3% and revenue growth at 73.2% a year. Prices are based on the 11 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Solar panel, branded pharma and IT stocks offer a focused view of a sector where demand keeps widening. Emmvee Photovoltaic Power, Ajanta Pharma and Mindteck (India) cover a solar modules maker, a branded pharmaceuticals company and an IT services company.<\/p>\n<p>This list covers three solar panel, branded pharma and IT stocks with complete current figures: Emmvee Photovoltaic Power, Ajanta Pharma and Mindteck (India). Every figure comes from the latest reported financials and the 11 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=solar-modules-maker-specialty-medicines-company-and-it-engineering-services-company-stocks-roadmap-highland-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/solar-modules-maker-specialty-medicines-company-and-it-engineering-services-company-stocks-roadmap-highland-list\/#What_Are_Solar_Panel_Branded_Pharma_and_IT_Stocks\" title=\"What Are Solar Panel, Branded Pharma and IT Stocks?\">What Are Solar Panel, Branded Pharma and IT Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/solar-modules-maker-specialty-medicines-company-and-it-engineering-services-company-stocks-roadmap-highland-list\/#Solar_Panel_Branded_Pharma_and_IT_Stocks_at_a_Glance\" title=\"Solar Panel, Branded Pharma and IT Stocks at a Glance\">Solar Panel, Branded Pharma and IT Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/solar-modules-maker-specialty-medicines-company-and-it-engineering-services-company-stocks-roadmap-highland-list\/#Why_Do_Solar_Panel_Branded_Pharma_and_IT_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Solar Panel, Branded Pharma and IT Stocks Have a Strong Roadmap in India?\">Why Do Solar Panel, Branded Pharma and IT Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/solar-modules-maker-specialty-medicines-company-and-it-engineering-services-company-stocks-roadmap-highland-list\/#Why_Emmvee_Photovoltaic_Power_Features_Among_These_Solar_Panel_Branded_Pharma_and_IT_Stocks\" title=\"Why Emmvee Photovoltaic Power Features Among These Solar Panel, Branded Pharma and IT Stocks\">Why Emmvee Photovoltaic Power Features Among These Solar Panel, Branded Pharma and IT Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/solar-modules-maker-specialty-medicines-company-and-it-engineering-services-company-stocks-roadmap-highland-list\/#Why_Ajanta_Pharma_Features_Among_These_Solar_Panel_Branded_Pharma_and_IT_Stocks\" title=\"Why Ajanta Pharma Features Among These Solar Panel, Branded Pharma and IT Stocks\">Why Ajanta Pharma Features Among These Solar Panel, Branded Pharma and IT Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/solar-modules-maker-specialty-medicines-company-and-it-engineering-services-company-stocks-roadmap-highland-list\/#Why_Mindteck_India_Features_Among_These_Solar_Panel_Branded_Pharma_and_IT_Stocks\" title=\"Why Mindteck (India) Features Among These Solar Panel, Branded Pharma and IT Stocks\">Why Mindteck (India) Features Among These Solar Panel, Branded Pharma and IT Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/solar-modules-maker-specialty-medicines-company-and-it-engineering-services-company-stocks-roadmap-highland-list\/#Emmvee_Photovoltaic_Power_vs_Ajanta_Pharma_vs_Mindteck_India_on_Key_Financials\" title=\"Emmvee Photovoltaic Power vs Ajanta Pharma vs Mindteck (India) on Key Financials\">Emmvee Photovoltaic Power vs Ajanta Pharma vs Mindteck (India) on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/solar-modules-maker-specialty-medicines-company-and-it-engineering-services-company-stocks-roadmap-highland-list\/#Key_Risks_to_Check_Before_Investing_in_Solar_Panel_Branded_Pharma_and_IT_Stocks\" title=\"Key Risks to Check Before Investing in Solar Panel, Branded Pharma and IT Stocks\">Key Risks to Check Before Investing in Solar Panel, Branded Pharma and IT Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/solar-modules-maker-specialty-medicines-company-and-it-engineering-services-company-stocks-roadmap-highland-list\/#Final_Thoughts_on_Solar_Panel_Branded_Pharma_and_IT_Stocks\" title=\"Final Thoughts on Solar Panel, Branded Pharma and IT Stocks\">Final Thoughts on Solar Panel, Branded Pharma and IT Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/solar-modules-maker-specialty-medicines-company-and-it-engineering-services-company-stocks-roadmap-highland-list\/#What_are_solar_panel_branded_pharma_and_IT_stocks\" title=\"What are solar panel, branded pharma and IT stocks?\">What are solar panel, branded pharma and IT stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/solar-modules-maker-specialty-medicines-company-and-it-engineering-services-company-stocks-roadmap-highland-list\/#Which_solar_panel_branded_pharma_and_IT_stocks_are_covered_in_this_list\" title=\"Which solar panel, branded pharma and IT stocks are covered in this list?\">Which solar panel, branded pharma and IT stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/solar-modules-maker-specialty-medicines-company-and-it-engineering-services-company-stocks-roadmap-highland-list\/#Why_do_solar_panel_branded_pharma_and_IT_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do solar panel, branded pharma and IT stocks have a strong future roadmap in India?\">Why do solar panel, branded pharma and IT stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/solar-modules-maker-specialty-medicines-company-and-it-engineering-services-company-stocks-roadmap-highland-list\/#How_has_Emmvee_Photovoltaic_Power_performed_financially\" title=\"How has Emmvee Photovoltaic Power performed financially?\">How has Emmvee Photovoltaic Power performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/solar-modules-maker-specialty-medicines-company-and-it-engineering-services-company-stocks-roadmap-highland-list\/#How_has_Ajanta_Pharma_performed_financially\" title=\"How has Ajanta Pharma performed financially?\">How has Ajanta Pharma performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/solar-modules-maker-specialty-medicines-company-and-it-engineering-services-company-stocks-roadmap-highland-list\/#How_has_Mindteck_India_performed_financially\" title=\"How has Mindteck (India) performed financially?\">How has Mindteck (India) performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/solar-modules-maker-specialty-medicines-company-and-it-engineering-services-company-stocks-roadmap-highland-list\/#What_risks_should_investors_check_before_buying_solar_panel_branded_pharma_and_IT_stocks\" title=\"What risks should investors check before buying solar panel, branded pharma and IT stocks?\">What risks should investors check before buying solar panel, branded pharma and IT stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/solar-modules-maker-specialty-medicines-company-and-it-engineering-services-company-stocks-roadmap-highland-list\/#Is_this_list_of_solar_panel_branded_pharma_and_IT_stocks_investment_advice\" title=\"Is this list of solar panel, branded pharma and IT stocks investment advice?\">Is this list of solar panel, branded pharma and IT stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Solar_Panel_Branded_Pharma_and_IT_Stocks\"><\/span><strong>What Are Solar Panel, Branded Pharma and IT Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Solar panel, branded pharma and IT stocks are listed companies that make solar cells and modules for utilities, factories and homes, develop and sell branded medicines for eye, skin, heart and pain care, and provide software and engineering services to global clients. Their earnings depend on solar installations, prescription demand and client technology budgets.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Solar_Panel_Branded_Pharma_and_IT_Stocks_at_a_Glance\"><\/span><strong>Solar Panel, Branded Pharma and IT Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/emmvee\/emmvee-photovoltaic-pwr-l-share-price-today\">Emmvee Photovoltaic Power<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">265.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">16,672<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">40.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">32.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/ajantpharm\/ajanta-pharma-ltd-share-price-today\">Ajanta Pharma<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,319.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">41,241<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">23.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.06<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/mindteck\/mindteck-(india)-ltd-share-price-today\">Mindteck (India)<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">137.31<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">436<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.6<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.4<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.01<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, Emmvee Photovoltaic Power and Mindteck (India) trade at a P\/E below the industry P\/E, while Ajanta Pharma trades above it, which reflects the growth the market already expects. Readers comparing solar panel, branded pharma and IT stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Solar_Panel_Branded_Pharma_and_IT_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Solar Panel, Branded Pharma and IT Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Solar panel, branded pharma and IT stocks have a strong roadmap in India because rapid solar capacity additions, steady demand for specialty medicines and wider outsourcing of technology work keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Solar modules.<\/strong> Utilities and homes add clean energy fast.<\/li>\n<li><strong>Branded pharma.<\/strong> Doctors prescribe trusted specialty brands.<\/li>\n<li><strong>IT services.<\/strong> Clients outsource engineering and software work.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Emmvee_Photovoltaic_Power_Features_Among_These_Solar_Panel_Branded_Pharma_and_IT_Stocks\"><\/span><strong>Why Emmvee Photovoltaic Power Features Among These Solar Panel, Branded Pharma and IT Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the solar panel, branded pharma and IT stocks on this list, Emmvee Photovoltaic Power is a Bengaluru-based manufacturer of solar photovoltaic modules and solar cells for utility-scale, commercial and rooftop customers.<\/p>\n<p>Revenue rose from Rs 567 crore in FY22 to Rs 5,103 crore in FY26, a compound annual growth rate of 73.2%. Net profit for FY26 was Rs 1,082 crore, a net margin of 21.2%.<\/p>\n<p>The company has a return on equity of 32.3%, a debt to equity ratio of 0.25 and a market capitalisation of Rs 16,672 crore. The stock trades at a P\/E of 11.8, below the industry P\/E of 40.7.<\/p>\n<p><strong>Roadmap:<\/strong> The company is expanding module and cell capacity to serve India&#8217;s rising solar installations and is moving toward a more integrated manufacturing chain. Policy support for locally made solar equipment helps its order flow.<\/p>\n<p><strong>What to watch:<\/strong> Follow capacity commissioning, order inflows and solar policy changes.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Ajanta_Pharma_Features_Among_These_Solar_Panel_Branded_Pharma_and_IT_Stocks\"><\/span><strong>Why Ajanta Pharma Features Among These Solar Panel, Branded Pharma and IT Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the photovoltaic, prescription brand and software shares on this list, Ajanta Pharma is a specialty pharmaceutical company that sells branded generics in India and in emerging markets across Asia and Africa, with a focus on ophthalmology, dermatology, cardiology and pain management, and also sells generics in the United States.<\/p>\n<p>In the June 2026 quarter, revenue grew 27.7% year on year to Rs 1,697 crore, while net profit rose 30.9% to Rs 334 crore. Revenue rose from Rs 3,457 crore in FY22 to Rs 5,625 crore in FY26, a compound annual growth rate of 12.9%.<\/p>\n<p>Net profit grew from Rs 713 crore in FY22 to Rs 1,056 crore in FY26, which works out to a compound annual growth rate of 10.3%. The company has a return on equity of 23.3%, a debt to equity ratio of 0.06 and a market capitalisation of Rs 41,241 crore. The stock trades at a P\/E of 36.3, above the industry P\/E of 36.0.<\/p>\n<p><strong>Roadmap:<\/strong> The company concentrates on niche therapies where it holds leading positions and has a wide field force in India and Africa. A steady flow of new launches and a debt-free balance sheet support expansion in branded markets.<\/p>\n<p><strong>What to watch:<\/strong> Monitor the pace of new launches in branded markets and the momentum in the United States generics business.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Mindteck_India_Features_Among_These_Solar_Panel_Branded_Pharma_and_IT_Stocks\"><\/span><strong>Why Mindteck (India) Features Among These Solar Panel, Branded Pharma and IT Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Mindteck (India) provides IT services including software development, data and analytics and cloud support to clients across healthcare, financial services and other industries.<\/p>\n<p>The company has a return on equity of 10.4%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 436 crore. The stock trades at a P\/E of 14.0, below the industry P\/E of 17.6.<\/p>\n<p>Revenue rose from Rs 304 crore in FY22 to Rs 417 crore in FY26, a compound annual growth rate of 8.3%. Net profit grew from Rs 20.8 crore in FY23 to Rs 31.5 crore in FY26, which works out to a compound annual growth rate of 14.9%. In the June 2026 quarter, revenue grew 2.8% year on year to Rs 107 crore.<\/p>\n<p><strong>Roadmap:<\/strong> The company is focusing on digital engineering, data and cloud services for existing clients and widening its work in specialised industries. Long client relationships support steady project flow.<\/p>\n<p><strong>What to watch:<\/strong> Monitor client additions, utilisation and currency movements.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Emmvee_Photovoltaic_Power_vs_Ajanta_Pharma_vs_Mindteck_India_on_Key_Financials\"><\/span><strong>Emmvee Photovoltaic Power vs Ajanta Pharma vs Mindteck (India) on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three solar panel, branded pharma and IT stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Emmvee Photovoltaic Power<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">567<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,103<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">73.2%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,082<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">21.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Ajanta Pharma<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,457<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,625<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12.9%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,056<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Mindteck (India)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">304<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">417<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">8.3%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">31.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7.6%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Emmvee Photovoltaic Power posts the highest return on equity in this group at 32.3%. Ajanta Pharma has the largest FY26 revenue at Rs 5,625 crore, and Emmvee Photovoltaic Power shows the fastest revenue growth with a 73.2% compound annual rate. A useful habit with solar panel, branded pharma and IT stocks is to check each new quarterly result against the capacity plans the company described earlier.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Solar_Panel_Branded_Pharma_and_IT_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Solar Panel, Branded Pharma and IT Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these solar panel, branded pharma and IT stocks, the main points are: Long-term photovoltaic, prescription brand and software shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Module prices.<\/strong> Solar equipment prices and policy support can change returns.<\/li>\n<li><strong>Pricing pressure.<\/strong> Generic prices can change by market.<\/li>\n<li><strong>Client budgets.<\/strong> Spending can vary with global conditions.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter solar panel, branded pharma and IT stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Solar_Panel_Branded_Pharma_and_IT_Stocks\"><\/span><strong>Final Thoughts on Solar Panel, Branded Pharma and IT Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Solar panel, branded pharma and IT stocks reward patient research into demand, execution and financial strength. Emmvee Photovoltaic Power, Ajanta Pharma and Mindteck (India) each have a clear plan to grow. Based on the 11 November 2026 close, Emmvee Photovoltaic Power trades at Rs 265.8, Ajanta Pharma at Rs 3,319.6 and Mindteck (India) at Rs 137.31.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track solar panel, branded pharma and IT stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_solar_panel_branded_pharma_and_IT_stocks\"><\/span><strong>What are solar panel, branded pharma and IT stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Solar panel, branded pharma and IT stocks are listed companies that make solar cells and modules for utilities, factories and homes, develop and sell branded medicines for eye, skin, heart and pain care, and provide software and engineering services to global clients. Their earnings depend on solar installations, prescription demand and client technology budgets. This list looks at three of them, Emmvee Photovoltaic Power, Ajanta Pharma and Mindteck (India), using reported FY22 to FY26 financials and the 11 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_solar_panel_branded_pharma_and_IT_stocks_are_covered_in_this_list\"><\/span><strong>Which solar panel, branded pharma and IT stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Emmvee Photovoltaic Power, Ajanta Pharma and Mindteck (India). Based on the 11 November 2026 close, Emmvee Photovoltaic Power traded at Rs 265.8, Ajanta Pharma at Rs 3,319.6 and Mindteck (India) at Rs 137.31. Their return on equity ranges from 10.4% to 32.3%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.3% to 73.2%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_solar_panel_branded_pharma_and_IT_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do solar panel, branded pharma and IT stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Solar panel, branded pharma and IT stocks have a strong roadmap in India because rapid solar capacity additions, steady demand for specialty medicines and wider outsourcing of technology work keep widening the market for these companies. The main drivers are as follows. Solar modules. Utilities and homes add clean energy fast. Branded pharma. Doctors prescribe trusted specialty brands. IT services. Clients outsource engineering and software work. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Emmvee_Photovoltaic_Power_performed_financially\"><\/span><strong>How has Emmvee Photovoltaic Power performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 567 crore in FY22 to Rs 5,103 crore in FY26, a compound annual growth rate of 73.2%. Net profit for FY26 was Rs 1,082 crore, a net margin of 21.2%. The company has a return on equity of 32.3%, a debt to equity ratio of 0.25 and a market capitalisation of Rs 16,672 crore. The stock trades at a P\/E of 11.8, below the industry P\/E of 40.7. Looking ahead, the company is expanding module and cell capacity to serve India&#8217;s rising solar installations and is moving toward a more integrated manufacturing chain. Policy support for locally made solar equipment helps its order flow.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Ajanta_Pharma_performed_financially\"><\/span><strong>How has Ajanta Pharma performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 3,457 crore in FY22 to Rs 5,625 crore in FY26, a compound annual growth rate of 12.9%. Net profit grew from Rs 713 crore in FY22 to Rs 1,056 crore in FY26, which works out to a compound annual growth rate of 10.3%. In the June 2026 quarter, revenue grew 27.7% year on year to Rs 1,697 crore, while net profit rose 30.9% to Rs 334 crore. The company has a return on equity of 23.3%, a debt to equity ratio of 0.06 and a market capitalisation of Rs 41,241 crore. The stock trades at a P\/E of 36.3, above the industry P\/E of 36.0. Looking ahead, the company concentrates on niche therapies where it holds leading positions and has a wide field force in India and Africa. A steady flow of new launches and a debt-free balance sheet support expansion in branded markets.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Mindteck_India_performed_financially\"><\/span><strong>How has Mindteck (India) performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 304 crore in FY22 to Rs 417 crore in FY26, a compound annual growth rate of 8.3%. Net profit grew from Rs 20.8 crore in FY23 to Rs 31.5 crore in FY26, which works out to a compound annual growth rate of 14.9%. In the June 2026 quarter, revenue grew 2.8% year on year to Rs 107 crore. The company has a return on equity of 10.4%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 436 crore. The stock trades at a P\/E of 14.0, below the industry P\/E of 17.6. Looking ahead, the company is focusing on digital engineering, data and cloud services for existing clients and widening its work in specialised industries. Long client relationships support steady project flow.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_solar_panel_branded_pharma_and_IT_stocks\"><\/span><strong>What risks should investors check before buying solar panel, branded pharma and IT stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying solar panel, branded pharma and IT stocks. Module prices. Solar equipment prices and policy support can change returns. Pricing pressure. Generic prices can change by market. Client budgets. Spending can vary with global conditions. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_solar_panel_branded_pharma_and_IT_stocks_investment_advice\"><\/span><strong>Is this list of solar panel, branded pharma and IT stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 11 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are solar panel, branded pharma and IT stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Solar panel, branded pharma and IT stocks are listed companies that make solar cells and modules for utilities, factories and homes, develop and sell branded medicines for eye, skin, heart and pain care, and provide software and engineering services to global clients. Their earnings depend on solar installations, prescription demand and client technology budgets. This list looks at three of them, Emmvee Photovoltaic Power, Ajanta Pharma and Mindteck (India), using reported FY22 to FY26 financials and the 11 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which solar panel, branded pharma and IT stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Emmvee Photovoltaic Power, Ajanta Pharma and Mindteck (India). Based on the 11 November 2026 close, Emmvee Photovoltaic Power traded at Rs 265.8, Ajanta Pharma at Rs 3,319.6 and Mindteck (India) at Rs 137.31. Their return on equity ranges from 10.4% to 32.3%, and their revenue compound annual growth from FY22 to FY26 ranges from 8.3% to 73.2%.\"}},{\"@type\":\"Question\",\"name\":\"Why do solar panel, branded pharma and IT stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Solar panel, branded pharma and IT stocks have a strong roadmap in India because rapid solar capacity additions, steady demand for specialty medicines and wider outsourcing of technology work keep widening the market for these companies. The main drivers are as follows. Solar modules. Utilities and homes add clean energy fast. Branded pharma. Doctors prescribe trusted specialty brands. IT services. Clients outsource engineering and software work. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Emmvee Photovoltaic Power performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 567 crore in FY22 to Rs 5,103 crore in FY26, a compound annual growth rate of 73.2%. Net profit for FY26 was Rs 1,082 crore, a net margin of 21.2%. The company has a return on equity of 32.3%, a debt to equity ratio of 0.25 and a market capitalisation of Rs 16,672 crore. The stock trades at a P\/E of 11.8, below the industry P\/E of 40.7. Looking ahead, the company is expanding module and cell capacity to serve India's rising solar installations and is moving toward a more integrated manufacturing chain. Policy support for locally made solar equipment helps its order flow.\"}},{\"@type\":\"Question\",\"name\":\"How has Ajanta Pharma performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 3,457 crore in FY22 to Rs 5,625 crore in FY26, a compound annual growth rate of 12.9%. Net profit grew from Rs 713 crore in FY22 to Rs 1,056 crore in FY26, which works out to a compound annual growth rate of 10.3%. In the June 2026 quarter, revenue grew 27.7% year on year to Rs 1,697 crore, while net profit rose 30.9% to Rs 334 crore. The company has a return on equity of 23.3%, a debt to equity ratio of 0.06 and a market capitalisation of Rs 41,241 crore. The stock trades at a P\/E of 36.3, above the industry P\/E of 36.0. Looking ahead, the company concentrates on niche therapies where it holds leading positions and has a wide field force in India and Africa. A steady flow of new launches and a debt-free balance sheet support expansion in branded markets.\"}},{\"@type\":\"Question\",\"name\":\"How has Mindteck (India) performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 304 crore in FY22 to Rs 417 crore in FY26, a compound annual growth rate of 8.3%. Net profit grew from Rs 20.8 crore in FY23 to Rs 31.5 crore in FY26, which works out to a compound annual growth rate of 14.9%. In the June 2026 quarter, revenue grew 2.8% year on year to Rs 107 crore. The company has a return on equity of 10.4%, a debt to equity ratio of 0.01 and a market capitalisation of Rs 436 crore. The stock trades at a P\/E of 14.0, below the industry P\/E of 17.6. Looking ahead, the company is focusing on digital engineering, data and cloud services for existing clients and widening its work in specialised industries. Long client relationships support steady project flow.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying solar panel, branded pharma and IT stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying solar panel, branded pharma and IT stocks. Module prices. Solar equipment prices and policy support can change returns. Pricing pressure. Generic prices can change by market. Client budgets. Spending can vary with global conditions. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of solar panel, branded pharma and IT stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 11 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Solar Panel, Branded Pharma and IT Stocks with a strong future roadmap: Emmvee Photovoltaic Power, Ajanta Pharma and Mindteck (India). Compare price, valuation, return on equity and revenue growth as of 11 November 2026.<\/p>\n","protected":false},"author":36,"featured_media":344584,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[13959,3803,22634,17203,17860,22635,22636,12570,22633,22637],"class_list":["post-344585","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-ajanta-pharma","tag-best-stocks","tag-branded-pharma-and-it-stocks","tag-emmvee-photovoltaic-power","tag-mindteck-india","tag-photovoltaic","tag-prescription-brand-and-software-shares","tag-solar-module-maker","tag-solar-panel","tag-specialty-medicine-and-tech-services-stocks"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["344584"],"rank_math_title":["Solar Module, Branded Pharma and IT Services Stocks"],"rank_math_description":["Compare 3 solar panel, branded pharma and IT stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 11 Nov 2026."],"rank_math_focus_keyword":["solar panel, branded pharma and IT stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-solar-modules-maker-specialty-medicines-company-and-it-engineering-services.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/344585","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/36"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=344585"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/344585\/revisions"}],"predecessor-version":[{"id":344586,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/344585\/revisions\/344586"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/344584"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=344585"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=344585"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=344585"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}